Work

Stick With Intravenous or Give Subcutaneous a Shot? Time and Other Considerations When Evaluating Cancer Drug Formulations

Year: 2024

Type: editorial

Abstract: Time and other considerations when evaluating a switch to newer drug formulations (eg, subQ vs IV).

Source: JCO Oncology Practice

DOI: 10.1200/op-24-00501

Authors: Arjun Gupta, Michelle Tregear, Makala B. Pace, Rachel I. Vogel

Institutions: University of Minnesota, National Cancer Coalition, Huntsman Cancer Institute, University of Utah Health Care, Masonic Cancer Center

Language: English

Topic: Intramuscular injections and effects

Subfield: Emergency Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G1345980661, G136135454, Time toxicity of cancer: the time demands of cancer-related activities and their impact on well-being and quality of life, Cancer Center Support Grant

OpenAlex ID: W4401244752

Cites: 14

Cited by: 8

Related to: 10